Inject Care Parenterals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Inject Care Parenterals Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $6.2M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Inject Care Parenterals Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $6.2M Trade | TransData Nexus

Inject Care Parenterals Private Limited

Indian Pharmaceutical Exporter · Advanced Antibiotics Specialist · $6.2M Total Trade · DGFT Verified

Inject Care Parenterals Private Limited is an Indian pharmaceutical exporter with a total trade value of $6.2M across 3 products in 1 therapeutic categories. Based on 137 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ceftriaxone ($5.5M), Piperacillin ($510.9K), Ceftazidime ($172.9K).

Inject Care Parenterals Private Limited — Export Portfolio & Destination Treemap

Inject Care Parenterals Private Limited pharmaceutical export portfolio — 3 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Inject Care Parenterals Private Limited? — Company Overview & Market Position

Inject Care Parenterals Private Limited, established on August 2, 2002, is a private limited company headquartered in Vapi, Gujarat, India. The company specializes in the manufacturing of dry powder penicillin and cephalosporin injectables, serving both domestic and international markets. With an authorized and paid-up capital of ₹32.00 crore, Inject Care Parenterals has demonstrated consistent growth and financial stability.

As of March 31, 2024, the company employed 213 professionals, reflecting its commitment to quality and operational excellence. The leadership team comprises key directors:

- Atish Dilip Patel – Whole-Time Director, appointed on April 11, 2007. - Alpesh Dilip Patel – Director, appointed on June 14, 2014. - Dilip Chimanbhai Patel – Director, appointed on April 11, 2007. - Ashai Dilip Patel – Whole-Time Director, appointed on April 2, 2009.

The company's registered office is located at Plot No. 130 Silvassa Road, Vapi, Gujarat, 396195, India.

What Does Inject Care Parenterals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Ceftriaxone$5.5M

Product Portfolio — Top 3 by Export Value

Inject Care Parenterals Private Limited exports 3 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ceftriaxone	Advanced Antibiotics	$5.5M	111	1.9%	8
2	Piperacillin	Advanced Antibiotics	$510.9K	21	0.6%	14
3	Ceftazidime	Advanced Antibiotics	$172.9K	5	1.6%	10

Inject Care Parenterals Private Limited exports 3 pharmaceutical products across 1 therapeutic categories with a total export value of $6.2M. The top category is Advanced Antibiotics (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Inject Care Parenterals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

As of March 31, 2024, the company employed 213 professionals, reflecting its commitment to quality and operational excellence. The leadership team comprises key directors:

Atish Dilip Patel – Whole-Time Director, appointed on April 11, 2007.
Alpesh Dilip Patel – Director, appointed on June 14, 2014.
Dilip Chimanbhai Patel – Director, appointed on April 11, 2007.
Ashai Dilip Patel – Whole-Time Director, appointed on April 2, 2009.

The company's registered office is located at Plot No. 130 Silvassa Road, Vapi, Gujarat, 396195, India.

2Manufacturing Facilities

Inject Care Parenterals operates a state-of-the-art manufacturing facility in Vapi, Gujarat, India. The plant is designed and constructed in accordance with international standards, ensuring compliance with Good Manufacturing Practices (GMP). The facility boasts a substantial manufacturing capacity, producing 10 million vials per month on a single shift. This high capacity enables the company to undertake contract manufacturing for several large players in both domestic and international markets.

3Key Leadership

The leadership team at Inject Care Parenterals Private Limited is composed of experienced professionals dedicated to steering the company towards continued success:

Atish Dilip Patel serves as the Whole-Time Director, having been appointed on April 11, 2007.
Alpesh Dilip Patel holds the position of Director, with an appointment date of June 14, 2014.
Dilip Chimanbhai Patel is also a Director, appointed on April 11, 2007.
Ashai Dilip Patel serves as the Whole-Time Director, with an appointment date of April 2, 2009.

These leaders, along with the company's dedicated team, drive Inject Care Parenterals' commitment to quality and innovation in the pharmaceutical manufacturing sector.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Inject Care Parenterals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Inject Care Parenterals Private Limited has established a significant presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility in Vapi, Gujarat, India, is EU GMP and PIC/s certified, ensuring compliance with international standards.

While specific details regarding regulatory filings, approvals, and market access status in the United States, European Union, United Kingdom, Australia, and Japan are not publicly disclosed, the company's adherence to EU GMP and PIC/s standards indicates a strong foundation for meeting the regulatory requirements of these markets. The substantial manufacturing capacity of 10 million vials per month further positions Inject Care Parenterals to cater to the demands of these regulated markets effectively.

2Emerging Markets

Inject Care Parenterals Private Limited has expanded its reach to emerging markets across Africa, Latin America, and Southeast Asia. The company's adherence to WHO prequalification standards has facilitated access to these regions, enabling the supply of quality pharmaceutical products to a broader patient base. By meeting WHO prequalification criteria, Inject Care Parenterals demonstrates its commitment to global health standards and enhances its competitiveness in emerging markets.

Geographic Strategy

Inject Care Parenterals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Inject Care Parenterals Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's adherence to EU GMP and PIC/s standards indicates a commitment to maintaining high-quality manufacturing practices, which are essential for FDA compliance. The substantial manufacturing capacity of 10 million vials per month further suggests the company's capability to meet the demands of regulated markets, including the United States.

2WHO & EU GMP

Inject Care Parenterals Private Limited's manufacturing facility in Vapi, Gujarat, India, is EU GMP and PIC/s certified, ensuring compliance with international standards. This certification reflects the company's commitment to maintaining high-quality manufacturing practices and positions it favorably for market access in regions that require such certifications.

3CDSCO & Indian Regulatory

Inject Care Parenterals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Inject Care Parenterals Private Limited operates in a competitive pharmaceutical manufacturing sector, facing competition from both domestic and international companies. Key competitors include Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences, and ApiJect. The company's focus on dry powder penicillin and cephalosporin injectables positions it in a specialized niche, allowing for targeted competition. Its adherence to EU GMP and PIC/s standards, along with a substantial manufacturing capacity of 10 million vials per month, provides a competitive edge in meeting the demands of both domestic and international markets.

2Key Differentiators

Inject Care Parenterals Private Limited distinguishes itself through several key strengths:

Regulatory Compliance: The company's manufacturing facility is EU GMP and PIC/s certified, ensuring adherence to international quality standards.

Manufacturing Capacity: With a production capacity of 10 million vials per month on a single shift, Inject Care Parenterals can meet substantial market demands and undertake contract manufacturing for large players.

Buyer Due Diligence Brief — Evaluating Inject Care Parenterals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Inject Care Parenterals Private Limited has demonstrated a strong track record in pharmaceutical manufacturing, with a focus on quality and regulatory compliance. The company's substantial export volume and consistent production capacity of 10 million vials per month indicate reliability and the ability to meet large-scale demands.

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Inject Care Parenterals Private Limited

How many pharmaceutical products does Inject Care Parenterals Private Limited export from India?

Inject Care Parenterals Private Limited exports 3 pharmaceutical products across 1 therapeutic categories. The top exports are Ceftriaxone ($5.5M), Piperacillin ($510.9K), Ceftazidime ($172.9K). Total export value is $6.2M.

What is Inject Care Parenterals Private Limited's total pharmaceutical export value?

Inject Care Parenterals Private Limited's total pharmaceutical export value is $6.2M, based on 137 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Inject Care Parenterals Private Limited cover?

Inject Care Parenterals Private Limited exports across 1 therapeutic categories. The largest are Advanced Antibiotics (100.0%, 3 products).

Get Full Inject Care Parenterals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.